Table 1.
Control group | Cr group | Ac group (n10) | Oral-Cr/Ac group (n10) | ip-Cr/Ac group (n10) | p value | |||
---|---|---|---|---|---|---|---|---|
Oral-saline (n5) | ip-saline (n5) | Oral-Cr (n5) | ip-Cr (n5) | |||||
Body weight (gm) | 242.6 ± 21.8 | 232.6 ± 23.6 | 233.5 ± 14.7 | 229.2 ± 16.4 | 201.3 ± 11.3a | 221.4 ± 24.5 | 232.5 ± 18.2c | 0.0031 |
Wet lung weight (gm) | 1.4 ± 0.2 | 1.5 ± 0.4 | 1.6 ± 0.4 | 1.4 ± 0.6 | 2.3 ± 0.7a | 1.9 ± 0.6 | 1.8 ± 0.4 | 0.0183 |
Lung index* | 6.4 ± 2.1 | 6.5 ± 1.3 | 7.2 ± 3.1 | 7.9 ± 3.5 | 10.2 ± 0.7a | 8.1 ± 1.3c | 6.9 ± 0.9c | 0.0013 |
Dry lung weight (gm) | 0.52 ± 0.14 | 0.49 ± 0.1 | 0.5 ± 0.04 | 0.53 ± 0.05 | 0.6 ± 0.2 | 0.56 ± 0.6 | 0.62 ± 0.7 | 0.9966 |
W/D % | 3.3 ± 1.1 | 2.9 ± 1.5 | 3.2 ± 0.7 | 3 ± 0.4 | 6.4 ± 1.7b | 4.7 ± 1.3c | 3.9 ± 0.6d | < 0.001 |
One-way ANOVA, and Tukey HSD Post-hoc Test, p > 0.05: no significant differences, p < 0.05: significant differences.
*Lung index = wet lung weight (gr)/body weight (gr) × 1000; wet/ dry lung weight%.
ap < 0.05 versus oral-saline group.
bp < 0.001 significant versus oral-saline group.
cp < 0.05 versus Ac group.
dp < 0.001 significant versus Ac group.
ep < 0.05 versus oral-Cr/Ac group.
fp < 0.001 significant versus oral-Cr/Ac group.